Monopar Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2015 | — | — | $2.8M |
| Dec 2016 | $64.5K | $2.9M | $2.1M |
| Mar 2017 | — | — | $3.6M |
| Jun 2017 | — | — | $4.3M |
| Sep 2017 | — | — | $10.6M |
| Dec 2017 | $311.9K | $9.9M | $9.0M |
| Mar 2018 | $290.6K | $9.1M | $8.2M |
| Jun 2018 | $323.1K | $8.4M | $7.4M |
| Sep 2018 | $311.9K | $7.9M | $7.6M |
| Dec 2018 | $399.6K | $7.3M | $6.9M |
| Mar 2019 | $580.0K | $6.4M | $5.9M |
| Jun 2019 | $468.3K | $5.6M | $5.1M |
| Sep 2019 | $483.7K | $5.1M | $4.5M |
| Dec 2019 | $724.2K | $13.4M | $13.2M |
| Mar 2020 | $443.5K | $12.8M | $12.6M |
| Jun 2020 | $648.1K | $12.8M | $12.5M |
| Sep 2020 | $664.5K | $18.2M | $18.0M |
| Dec 2020 | $1.2M | $16.9M | $16.7M |
| Mar 2021 | $806.3K | $25.9M | $25.7M |
| Jun 2021 | $1.1M | $24.5M | $24.3M |
| Sep 2021 | $1.2M | $22.5M | $22.3M |
| Dec 2021 | $1.6M | $20.5M | $20.3M |
| Mar 2022 | $1.1M | $18.1M | $17.8M |
| Jun 2022 | $2.2M | $16.7M | $16.5M |
| Sep 2022 | $1.9M | $14.4M | $14.3M |
| Dec 2022 | $3.1M | $13.2M | $8.2M |
| Mar 2023 | $2.9M | $11.8M | $5.7M |
| Jun 2023 | $2.5M | $10.3M | $7.2M |
| Sep 2023 | $2.0M | $8.6M | $5.5M |
| Dec 2023 | $1.8M | $7.3M | $7.3M |
| Mar 2024 | $1.4M | $8.9M | $7.8M |
| Jun 2024 | $1.1M | $7.2M | $6.1M |
| Sep 2024 | $1.1M | $6.1M | $6.0M |
| Dec 2024 | $5.3M | $60.3M | $45.8M |
| Mar 2025 | $1.5M | $55.1M | $39.7M |
| Jun 2025 | $1.7M | $53.9M | $39.5M |
| Sep 2025 | $2.6M | $144.2M | $127.7M |
| Dec 2025 | $2.9M | $140.7M | $61.8M |
| Mar 2026 | $2.6M | $138.0M | $52.5M |
| Jun 2026 | $4.1M | $135.0M | $52.8M |